Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
compound houttuynia mixture
- Development stage
- Unknown
- Lead developer
- Conba Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Compound Houttuynia Mixture (Fufang Yuxingcao Heji) is a Traditional Chinese Medicine (TCM) oral liquid formulation developed and marketed by Zhejiang Conba Pharmaceutical. It is composed of five primary herbal extracts: *Houttuynia cordata*, *Scutellaria baicalensis*, *Forsythia suspensa*, *Lonicera japonica*, and *Isatis indigotica*. The mixture is widely used in China for the treatment of respiratory ailments, including acute pharyngitis, tonsillitis, and bronchitis, due to its purported heat-clearing and detoxifying properties. Pharmacologically, it exhibits broad-spectrum antibacterial and antiviral activities, as well as anti-inflammatory effects mediated through the inhibition of pro-inflammatory cytokines. Recent clinical research has explored its utility in pediatric acute pharyngitis and as a complementary treatment for COVID-19.
- Brand names
- Fufang Yuxingcao Heji
- Other names
- 复方鱼腥草合剂
02
Targets
TLR7 (Toll-like receptor 7)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on compound houttuynia mixture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on compound houttuynia mixture.